BPH Global Ltd (ASX:BP8)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Sourcing, Producing, Marketing and Selling of Traditional Medicines	352.38K	109.97K	339.00	494.01K	8.50M
Sourcing, Producing, Marketing and Selling of Traditional Medicines Growth	220.44%	32338.05%	-99.93%	-94.19%	1063.19%
Total	352.38K	109.97K	339.00	494.01K	8.50M
Total Growth	220.44%	32338.05%	-99.93%	-94.19%	1063.19%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Indonesia	235.99K	-	-	-	-
China	116.39K	109.97K	339.00	107.00	8.40M
China Growth	5.84%	32338.05%	216.82%	-100.00%	924578.41%
Singapore	-	-	-	493.90K	99.34K
Singapore Growth	-	-	-	397.19%	-86.38%
Total	352.38K	109.97K	339.00	494.01K	8.50M
Total Growth	220.44%	32338.05%	-99.93%	-94.19%	1063.19%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 25, 2026

Data Sources Report a data error